09sep12:00 pm1:00 pmProblems and perspectives of translational research in targeted theranostics
June-Key Chung, PhD Emeritus Professor Department of Nuclear Medicine, Cancer Research Institute Seoul National University College
Dr. Chung was a chairman of Nuclear Medicine Department of SNUMC and University Hospital, and a chief of Laboratory of Molecular Imaging & Therapy in Cancer Research Institute. He had served as faculty in SNUMC for 33 years, retiring 1 year ago. He was originally trained in Department of Internal Medicine, and became a founding member of Nuclear Medicine Department in 1995. He was a research fellow in the NIH on the application of monoclonal antibody in oncology. After returning to Korea in 1989, his research expanded and involved oncology PET, and report gene imaging. He is the medical doctor of thyroid clinic, and has performed many research projects related to radioiodine therapy and sodium/iodide symporter in patients with thyroid carcinoma. He has a particular interest in the translational research of several theranostics in oncology. He is the author of over 300 scientific manuscripts (H Index, 60) and 20 text books. He is a global leader in the field of nuclear medicine and molecular imaging. He served as Secretary General of World Federation of Nuclear Medicine & Biology for 4 years and Chairman of Asia Regional Cooperative Council of Nuclear Medicine for 10 years. In addition, he established Korean Society of Molecular Imaging in 2002, and Federation of Asia Societies for Molecular Imaging in 2006 and served as president in both societies. Due to these kinds of activities, he has been classified as a representative of Korean biomedical field. He is an international associate editor of Journal of Nuclear Medicine and editorial board member of more than 10 impact journals covering basic as well as clinical medicines.
Join via Zoom:
https://msu.zoom.us/j/740946330 | Meeting ID: 740 946 330
(Monday) 12:00 pm - 1:00 pm
775 Woodlot Dr